Equities Analysts Offer Predictions for OPCH FY2025 Earnings

Option Care Health, Inc. (NASDAQ:OPCH) – Analysts at Barrington Research decreased their FY2025 earnings estimates for shares of Option Care Health in a research note issued on Thursday, October 31st. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.12 for the year, down from their prior forecast of $1.40. Barrington Research currently has a “Outperform” rating and a $32.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.23 per share. Barrington Research also issued estimates for Option Care Health’s FY2026 earnings at $1.32 EPS.

Several other equities research analysts have also commented on the company. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities raised their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Truist Financial decreased their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the company from $38.00 to $26.00 in a report on Thursday. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $31.60.

Option Care Health Trading Up 4.6 %

Shares of OPCH opened at $24.11 on Monday. Option Care Health has a twelve month low of $22.84 and a twelve month high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.36 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.10 billion, a P/E ratio of 20.26, a PEG ratio of 1.74 and a beta of 1.32. The firm’s 50-day moving average is $30.49 and its two-hundred day moving average is $29.91.

Insider Activity

In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Large investors have recently added to or reduced their stakes in the business. UMB Bank n.a. increased its stake in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. increased its position in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. raised its stake in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the period. Finally, SageView Advisory Group LLC acquired a new position in shares of Option Care Health in the 1st quarter valued at $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.